Cargando…

454 Efficacy of Icatibant Versus Fresh Frozen Plasma for Attacks of Hereditary Angioedema: Analysis of Indivudual Symptoms by Attack Site

BACKGROUND: Hereditary angioedema (HAE) is a rare disorder characterized by funcional deficiency of C1 inhibitor (C1-INH) resulting in unpredictable, acute swelling attacks at varied locations. Icatibant, a selective bradikinin B2 receptor antagonist, is a novel treatment for acute attacks of HAE. T...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lara, Alicia, Esthela Hernandez, M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	World Allergy Organization Journal 2012
Materias:	Abstracts of the XXII World Allergy Congress
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3513098/ http://dx.doi.org/10.1097/01.WOX.0000412217.67551.bb

Ejemplares similares

165 Early Versus Delayed Treatment of Swelling Attacks with Icatibant, a Bradykinin 2 Receptor Antagonist in Patients With Hereditary Angioedema due to C1-INH Deficiency
por: Bork, Konrad, et al.
Publicado: (2012)

455 Characterization of the Factors Triggering an Edematous Attack in Hereditary Angioedema
por: Zotter, Zsuzsanna, et al.
Publicado: (2012)

164 Treatment of Acquired Angioedema with the Bradykinin Receptor Antagonist Icatibant
por: Siani, Maria Concetta, et al.
Publicado: (2012)

85 Clinical Efficacy of Recombinant Human C1 Inhibitor in Patients with Acute Hereditary Angioedema Attacks
por: Reshef, Avner, et al.
Publicado: (2012)

86 The Efficacy and Safety of Human Plasma-derived C1-Inhibitor Concentrate Administered for the Treatment of Attacks in Pediatric Patients with Hereditary Angioedema Due to C1-Inhibitor Deficiency
por: Farkas, Henriette, et al.
Publicado: (2012)

87 Treatment of Idiopathic Nonhistaminergic Angiodema with Icatibant
por: Lleonart, Ramon, et al.
Publicado: (2012)

588 Delayed Diagnosis of Hereditary Angioedema. A Case Report
por: González-Díaz, Sandra, et al.
Publicado: (2012)

457 Clinical Features and Outcome of 82 Patients with Hereditary Angioedema
por: D'Ottaviano, Fabricio Loffredo, et al.
Publicado: (2012)

586 Mucocutaneous Disease as a Presentation of Hereditary Angioedema. Report of 2 Cases
por: Alaniz, Angelica
Publicado: (2012)

Management of acute attacks of hereditary angioedema: potential role of icatibant
por: Longhurst, Hilary J
Publicado: (2010)

456 Hereditary Angioedema: Report of Ten Mexican Patients at West National Medical Center in Guadalajara City
por: Madrigal, Ileana
Publicado: (2012)

84 Immuno-Safety of Recombinant Human C1 Inhibitor in Patients With Hereditary Angioedema: An Integrated Analysis
por: Hack, Erik, et al.
Publicado: (2012)

549 Management of Twenty-Five Pediatric Patients with Hereditary Angioedema (Hae) Undergoing Home Treatment—A Clinical Surveillance Program
por: Martinez-Saguer, Inmaculada, et al.
Publicado: (2012)

462 When Honeybees Attack: Adrenal Insufficiency as a Late Consequence of Massive Exposure
por: Robinson, David
Publicado: (2012)

458 Differences of Complement Activation Profile between Type I and Type II of Hereditary Angioedema Due to C1-inhibitor Deficiency
por: Csuka, Dorottya, et al.
Publicado: (2012)

83 Hereditary Angioedema and Normal C1-Inhibitor (HAE TYPE III): A Novel Mutation in the Coagulation Factor 12 Gene
por: Bork, Konrad, et al.
Publicado: (2012)

Continued icatibant use across recurrent attacks in adolescents with hereditary angioedema
por: Farkas, Henriette, et al.
Publicado: (2021)

163 The Efficacy of Human Plasma-Derived C1-Inhibitor Concentrate Used for Prophylactic Treatment in Patients With Hereditary Angioedema Due to C1-Inhibitor Deficiency
por: Csuka, Dorottya, et al.
Publicado: (2012)

Hereditary Angioedema Attacks Resolve Faster and Are Shorter after Early Icatibant Treatment
por: Maurer, Marcus, et al.
Publicado: (2013)

Analysis of icatibant for the treatment of laryngeal hereditary angioedema attacks in the FAST-3 study
por: Yang, William, et al.
Publicado: (2014)

594 Life-Threatening Angioedema without Urticaria (Ae-U)
por: Corey, Jacquelynne, et al.
Publicado: (2012)

591 A Case of Idiopathic Recurrent Isolated Orbital Angioedema with Exophthalmos
por: Talreja, Neetu, et al.
Publicado: (2012)

580 Eleven Cases of Angioedema with Eosinophilia Treated in a Single Hospital in Japan
por: Nakachi, Shinichiro, et al.
Publicado: (2012)

The Icatibant Outcome Survey: treatment of laryngeal angioedema attacks
por: Longhurst, Hilary J., et al.
Publicado: (2016)

590 A Case of Chronic Urticaria Complicated by Raoultella Ornithinolytica Urinary Tract Infection, Bronchospasm and Angioedema
por: Lehloenya, Rannakoe, et al.
Publicado: (2012)

Breakthrough attacks in patients with hereditary angioedema receiving long-term prophylaxis are responsive to icatibant: findings from the Icatibant Outcome Survey
por: Aberer, Werner, et al.
Publicado: (2017)

Icatibant, an inhibitor of bradykinin receptor 2, for hereditary angioedema attacks: prospective experimental single-cohort study
por: Campos, Regis Albuquerque, et al.
Publicado: (2014)

Effectiveness of icatibant for treatment of hereditary angioedema attacks is not affected by body weight: findings from the Icatibant Outcome Survey, a cohort observational study
por: Caballero, Teresa, et al.
Publicado: (2018)

An evidence-based review of the potential role of icatibant in the treatment of acute attacks in hereditary angioedema type I and II
por: Floccard, Bernard, et al.
Publicado: (2012)

Hereditary angioedema: epidemiology, management, and role of icatibant
por: Ghazi, Aasia, et al.
Publicado: (2013)

391 Description of Drug Allergy Study Conducted in a Teaching Hospital between October 2007 and March 2011
por: Rodríguez Martínez, Consuelo Fernanda, et al.
Publicado: (2012)

A novel therapeutic concept for the treatment of acute angioedema attacks in hereditary angioedema patients: multiple successful treatments even in severe swelling attacks with the bradykinin-B2 receptor antagonist Icatibant
por: Bas, M, et al.
Publicado: (2006)

174 Reduction in Allergic Rhinitis Index by Decreasing Aero-Allergens and Malodor Causing Volatile Organic Compounds by Luna Air Purifiers Using Photo-Catalytic Oxidation (PCO) Technology
por: Ghosh, Nabarun, et al.
Publicado: (2012)

Therapeutic trial in hereditary angioedema type III: Icatibant
por: Garro, Laila Sabino, et al.
Publicado: (2015)

The complex role of kininogens in hereditary angioedema
por: Kaplan, Allen P., et al.
Publicado: (2022)

177 Effect of EPA-DHA Supplementation on Forced Expiratory Volume in One Second (FEV1) and Triglycerides in Obese Adolescents With Hypertriglyceridemia
por: Berreondo, Nancy Mendez
Publicado: (2012)

365 Patch Testing Results in Contact Dermatitis from the Allergist's Perspective
por: Aquino, Marcella, et al.
Publicado: (2012)

116 Genome-Wide Association Studies of Asthma Indicate Opposite Immunopathogenesis Direction From Autoimmune Diseases
por: Li, Xingnan, et al.
Publicado: (2012)

180 Selecting Primal Therapy Appropriate for the Type of Pollinosis—Topic-J Study
por: Okubo, Kimihiro, et al.
Publicado: (2012)

502 Plasminogen Activator Inhibitor-1, Fibrinogen and Lung Function in Adolescents with Asthma and Obesity
por: Huang, Fengyang
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_g3j25u99int5g9pov7c06hkn2l